Last 12 months
Inside the activity.
0 purchase rows · 17 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 4 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 512 | $0.00 Strike: $5.70 | $0.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · derivative · entry 10 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 512 shares Expires 2018-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options were granted on October 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.05 | $0.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · derivative · entry 9 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-07-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options were granted on July 30, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,500 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · derivative · entry 8 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,500 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted on May 28, 2008 and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
SaleCommon Stock | 58,112 | $21.39 | $1,243,015.68 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 6 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,479 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.08 to $21.65 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionCommon Stock | 25,000 | $6.73 | $168,250.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 5 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionCommon Stock | 21,100 | $6.27 | $132,297.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 4 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionCommon Stock | 512 | $5.70 | $2,918.40 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 3 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.05 | $100,500.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC |
Seith Douglas JChief Operating Officer
|
Exercise / conversionCommon Stock | 1,500 | $10.10 | $15,150.00 |
DisclosureSEC source: 0001209191-17-040121 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 16:12 UTC |
Lanning Mark RDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.50 | $0.00 |
DisclosureSEC source: 0001209191-17-038527 · doc4.xml · derivative · entry 3 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| June 07, 2017 Filed Jun 8, 2017 16:12 UTC |
Lanning Mark RDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.50 | $95,000.00 |
DisclosureSEC source: 0001209191-17-038527 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:23 UTC |
Collar Mark ADirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035356 · doc4.xml · nonDerivative · entry 1 Collar Mark A · CIK 0001426353 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,767 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:48 UTC |
Lanning Mark RDirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035451 · doc4.xml · nonDerivative · entry 1 Lanning Mark R · CIK 0001353679 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,005 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:53 UTC |
WEHRWEIN SVENDirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035460 · doc4.xml · nonDerivative · entry 1 WEHRWEIN SVEN · CIK 0001205069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 16:35 UTC |
JOHNSTON RICHARD MDirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035412 · doc4.xml · nonDerivative · entry 1 JOHNSTON RICHARD M · CIK 0001211913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 21:01 UTC |
WHITE ROBERT S.Director
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035471 · doc4.xml · nonDerivative · entry 1 WHITE ROBERT S. · CIK 0001571208 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,605 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:41 UTC |
Krell Elizabeth DDirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035439 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,967 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 24, 2017 Filed May 25, 2017 20:29 UTC |
Drake Scott WilliamDirector
|
GrantCommon Stock | 5,805 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-035388 · doc4.xml · nonDerivative · entry 1 Drake Scott William · CIK 0001527909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,805 F1 · security: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. Read SEC document |
| May 17, 2017 Filed May 17, 2017 20:35 UTC |
Krell Elizabeth DDirector
|
SaleCommon Stock | 10,000 | $21.44 | $214,400.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · nonDerivative · entry 2 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,162 F1 · price: This transaction was executed in multiple trades at prices ranging from $21.37 to $21.65 per share. The price reported above reflects the weighted average price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:35 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $10.10 | $0.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · derivative · entry 3 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2018-05-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on May 28, 2008 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 16, 2017 Filed May 17, 2017 20:35 UTC |
Krell Elizabeth DDirector
|
Exercise / conversionCommon Stock | 10,000 | $10.10 | $101,000.00 |
DisclosureSEC source: 0001209191-17-033108 · doc4.xml · nonDerivative · entry 1 Krell Elizabeth D · CIK 0001367742 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:51 UTC |
Hooven Michael DDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.50 | $0.00 |
DisclosureSEC source: 0001209191-17-030990 · doc4.xml · derivative · entry 6 Hooven Michael D · CIK 0001336090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2017-06-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. F7 · derivative.exercise_date: These options were granted on June 20, 2007 and are exercisable cumulatively at a rate of 33% per annum beginning one year from date of grant. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:51 UTC |
Hooven Michael DDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.50 | $95,000.00 |
DisclosureSEC source: 0001209191-17-030990 · doc4.xml · nonDerivative · entry 2 Hooven Michael D · CIK 0001336090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These shares were exercised pursuant to a 10b5-1 trading plan. Read SEC document |
| May 05, 2017 Filed May 9, 2017 20:51 UTC |
Hooven Michael DDirector
|
SaleCommon Stock | 10,000 | $22.08 | $220,800.00 |
DisclosureSEC source: 0001209191-17-030990 · doc4.xml · nonDerivative · entry 1 Hooven Michael D · CIK 0001336090 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,049 F1 · shares: These shares were sold pursuant to a 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades at prices ranging from $22.00 to $22.32 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:20 UTC |
JOHNSON B KRISTINEDirector
|
GrantCommon Stock | 9,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022563 · doc4.xml · nonDerivative · entry 1 JOHNSON B KRISTINE · CIK 0001231984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,469 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| March 21, 2017 Filed Mar 23, 2017 20:10 UTC |
GROVES REGINA EDirector
|
GrantCommon Stock | 9,469 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-022558 · doc4.xml · nonDerivative · entry 1 GROVES REGINA E · CIK 0001653877 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,469 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 33% annually over three years from date of grant. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 17:22 UTC |
LUX ANDREW LSVP, Ops & Quality
|
Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001209191-17-022088 · doc4.xml · derivative · entry 3 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-10-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on October 25, 2012 and are exercisable as to 25% of the shares upon the one-year anniversary of the date of grant and the remaining 75% thereafter vests and is exercisable in equal monthly installments on the same day of the month over the following three years. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 17:22 UTC |
LUX ANDREW LSVP, Ops & Quality
|
SaleCommon Stock | 20,000 | $18.85 | $377,000.00 |
DisclosureSEC source: 0001209191-17-022088 · doc4.xml · nonDerivative · entry 2 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,589 F1 · price: This transaction was executed in multiple trades at prices ranging from $18.64 to $18.99 per share. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 17, 2017 Filed Mar 21, 2017 17:22 UTC |
LUX ANDREW LSVP, Ops & Quality
|
Exercise / conversionCommon Stock | 20,000 | $6.27 | $125,400.00 |
DisclosureSEC source: 0001209191-17-022088 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,589 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:21 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Tax withholdingCommon Stock | 8,386 | $18.95 | $158,914.70 |
DisclosureSEC source: 0001209191-17-017514 · doc4.xml · nonDerivative · entry 2 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,179 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:21 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017514 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,565 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:18 UTC |
LUX ANDREW LSVP, Ops & Quality
|
Tax withholdingCommon Stock | 2,506 | $18.95 | $47,488.70 |
DisclosureSEC source: 0001209191-17-017480 · doc4.xml · nonDerivative · entry 2 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,589 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:18 UTC |
LUX ANDREW LSVP, Ops & Quality
|
GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017480 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,095 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:15 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 160,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017452 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 670,084 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:28 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 7,980 | $18.95 | $151,221.00 |
DisclosureSEC source: 0001209191-17-017558 · doc4.xml · nonDerivative · entry 2 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,421 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:28 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017558 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 169,401 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:24 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 9,566 | $18.95 | $181,275.70 |
DisclosureSEC source: 0001209191-17-017535 · doc4.xml · nonDerivative · entry 2 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 239,479 F2 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to Restricted Stock Awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:24 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-017535 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,045 F1 · price: The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2014 Stock Incentive Plan. The shares will vest 25% annually over four years from date of grant. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 16:27 UTC |
LUX ANDREW LSVP, Ops & Quality
|
Tax withholdingCommon Stock | 699 | $15.70 | $10,974.30 |
DisclosureSEC source: 0001209191-17-005720 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,095 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:38 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 2,746 | $15.70 | $43,112.20 |
DisclosureSEC source: 0001209191-17-005729 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,401 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 21:33 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 2,387 | $15.70 | $37,475.90 |
DisclosureSEC source: 0001209191-17-005725 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,045 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 21:45 UTC |
Noznesky Justin JSVP, Mktg & Business Develop
|
Tax withholdingCommon Stock | 2,432 | $18.93 | $46,037.76 |
DisclosureSEC source: 0001209191-17-003208 · doc4.xml · nonDerivative · entry 1 Noznesky Justin J · CIK 0001666600 · SVP, Mktg & Business Develop 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,565 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:11 UTC |
CARREL MICHAEL HDirector · President, CEO, & Director
|
GrantCommon Stock | 556 | $12.27 | $6,822.12 |
DisclosureSEC source: 0001209191-17-000826 · doc4.xml · nonDerivative · entry 1 CARREL MICHAEL H · CIK 0001230584 · Director · President, CEO, & Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 510,084 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 30, 2016. F2 · price: Closing price on December 30, 2016 was $19.57. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:17 UTC |
Wade M. AndrewSVP and CFO
|
GrantCommon Stock | 668 | $12.27 | $8,196.36 |
DisclosureSEC source: 0001209191-17-000857 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,147 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 30, 2016. F2 · price: Closing price on December 30, 2016 was $19.57. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 21:14 UTC |
Seith Douglas JChief Operating Officer
|
GrantCommon Stock | 109 | $12.27 | $1,337.43 |
DisclosureSEC source: 0001209191-17-000836 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,432 F1 · shares: Shares acquired pursuant to the AtriCure, Inc. 2008 Employee Stock Purchase Plan for the period ended December 30, 2016. F2 · price: Closing price on December 30, 2016 was $19.57. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 16:29 UTC |
LUX ANDREW LSVP, Ops & Quality
|
Tax withholdingCommon Stock | 800 | $19.41 | $15,528.00 |
DisclosureSEC source: 0001209191-16-157010 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,794 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:38 UTC |
Wade M. AndrewSVP and CFO
|
Tax withholdingCommon Stock | 1,199 | $19.41 | $23,272.59 |
DisclosureSEC source: 0001209191-16-157014 · doc4.xml · nonDerivative · entry 1 Wade M. Andrew · CIK 0001560591 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,479 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:33 UTC |
Seith Douglas JChief Operating Officer
|
Tax withholdingCommon Stock | 1,710 | $19.41 | $33,191.10 |
DisclosureSEC source: 0001209191-16-157012 · doc4.xml · nonDerivative · entry 1 Seith Douglas J · CIK 0001565823 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,323 F1 · shares: The Reporting Person has elected to transfer these shares to the Company to satisfy the tax withholding obligation incurred upon the vesting and release of shares previously acquired pursuant to a Restricted Stock Award. Read SEC document |
| December 19, 2016 Filed Dec 20, 2016 16:34 UTC |
ROBARDS KAREN PDirector
|
GiftCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-16-156116 · doc4.xml · nonDerivative · entry 1 ROBARDS KAREN P · CIK 0001141903 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,328 F1 · price: No consideration was received in connection with this gift to a charitable trust. Read SEC document |
| December 07, 2016 Filed Dec 9, 2016 16:26 UTC |
LUX ANDREW LSVP, Ops & Quality
|
SaleCommon Stock | 5,038 | $18.77 | $94,563.26 |
DisclosureSEC source: 0001209191-16-154413 · doc4.xml · nonDerivative · entry 1 LUX ANDREW L · CIK 0001213176 · SVP, Ops & Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,594 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.